Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Upwork
UPWK
$1.19B
| $30M | ﹤0.01% |
2,872,186
-18,706
| -0.6% | -$195K |
|
1752
Weis Markets
WMK
$1.86B
| $30M | ﹤0.01% |
434,964
+16,463
| +4% | +$1.12M |
|
1753
Collegium Pharmaceutical
COLL
$956M
| $30M | ﹤0.01% |
775,579
+5,464
| +0.7% | +$195K |
|
1754
Viasat
VSAT
$11.1B
| $30M | ﹤0.01% |
2,508,056
+122,472
| +5% | +$1.98M |
|
1755
Rocket Pharmaceuticals
RCKT
$394M
| $29.9M | ﹤0.01% |
1,617,866
+14,256
| +0.9% | +$292K |
|
1756
G-III Apparel Group
GIII
$1.5B
| $29.8M | ﹤0.01% |
977,331
+11,196
| +1% | +$307K |
|
1757
Ingles Markets
IMKTA
$1.67B
| $29.8M | ﹤0.01% |
399,190
+14,264
| +4% | +$1.05M |
|
1758
Gildan
GIL
$10.6B
| $29.7M | ﹤0.01% |
637,407
+41,735
| +7% | +$1.76M |
|
1759
QCR Holdings
QCRH
$1.7B
| $29.7M | ﹤0.01% |
401,193
+4,179
| +1% | +$297K |
|
|
FLNA
1760
Filana Therapeutics
FLNA
$48.1M
| $29.7M | ﹤0.01% |
1,008,593
+41,289
| +4% | +$951K |
|
1761
PureCycle Technologies
PCT
$1.45B
| $29.7M | ﹤0.01% |
3,124,445
+92,469
| +3% | +$619K |
|
1762
Ryanair
RYAAY
$31.3B
| $29.6M | ﹤0.01% |
656,244
+52,121
| +9% | +$2.26M |
|
1763
Brookdale Senior Living
BKD
$3.4B
| $29.6M | ﹤0.01% |
4,365,480
+89,344
| +2% | +$638K |
|
1764
UL Solutions
ULS
$15.8B
| $29.6M | ﹤0.01% |
600,936
+213,635
| +55% | +$10.4M |
|
1765
Navient
NAVI
$853M
| $29.6M | ﹤0.01% |
1,898,926
-37,610
| -2% | -$579K |
|
1766
Kforce
KFRC
$1.06B
| $29.5M | ﹤0.01% |
480,479
+18,386
| +4% | +$1.18M |
|
1767
Vita Coco
COCO
$3.6B
| $29.5M | ﹤0.01% |
1,041,662
+101,823
| +11% | +$2.71M |
|
|
CIM
1768
Chimera Investment
CIM
$1B
| $29.4M | ﹤0.01% |
1,859,330
+32,835
| +2% | +$492K |
|
1769
Harmony Biosciences
HRMY
$2.24B
| $29.4M | ﹤0.01% |
735,418
-13,285
| -2% | -$467K |
|
|
SCS
1770
DELISTED
Steelcase
SCS
| $29.4M | ﹤0.01% |
2,180,428
+22,507
| +1% | +$302K |
|
|
MTTR
1771
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $29.4M | ﹤0.01% |
6,534,162
+471,641
| +8% | +$2.06M |
|
1772
Leggett & Platt
LEG
$1.31B
| $29.4M | ﹤0.01% |
2,156,322
+60,166
| +3% | +$751K |
|
|
RC
1773
Ready Capital
RC
$308M
| $29.3M | ﹤0.01% |
3,838,284
+150,479
| +4% | +$1.28M |
|
1774
Xencor
XNCR
$1.55B
| $29.3M | ﹤0.01% |
1,455,350
+17,658
| +1% | +$331K |
|
|
HAPN
1775
Happen Inc
HAPN
$2.24B
| $29.3M | ﹤0.01% |
2,559,805
+42,429
| +2% | +$453K |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.